
Kratom Reports Surged in First Half of 2026
Poison centers recorded over 3,000 incidents as states moved to regulate the substance.
Live Poll
Should states ban all kratom sales instead of allowing a regulated market for adults?

Poison centers recorded over 3,000 incidents as states moved to regulate the substance.
Live Poll
Should states ban all kratom sales instead of allowing a regulated market for adults?
October 7, 2026
Trump Administration Proposed Homelessness Grant ChangesThe proposal focuses on addiction treatment and enforcement for federal homelessness grant criteria.
October 7, 2026
FDA Approved TONMYA for Fibromyalgia TreatmentThe FDA approved a new non-opioid fibromyalgia medication in August 2025 to help patients manage chronic pain.
October 6, 2026
Researchers Developed Patch to Treat Fentanyl OverdosesA new wearable device from Virginia Tech detects fentanyl and automatically delivers naloxone doses to the user.
October 6, 2026
NIDA Initiative Selected Psychoactive Drug StudyThe research team classified various drugs by analyzing unique brain-wide neuronal activation patterns.
October 6, 2026
Benzodiazepine Prescriptions Dropped Through 2024A national study found a significant reduction in dispensed benzodiazepine prescriptions between 2013 and 2024.
October 6, 2026
Mothers Against Drunk Driving Released Coaches' GuideThe new resource aims to help coaches prevent underage drinking and substance use among student-athletes.
October 5, 2026
Actress Hayden Panettiere Died From OverdoseThe 36-year-old actress was pronounced dead at an apartment complex in South Carolina on August 16.
October 5, 2026
University Researchers Developed Fentanyl VaccineThe team is preparing to request FDA approval for human trials following successful results in animal testing.
October 5, 2026
DEA Published Updated Drugs of Abuse ReportThe federal agency revised its comprehensive guide to reflect the recent rescheduling of medical marijuana.
October 5, 2026
FDA Requested Data on Ibogaine ResearchFederal regulators have opened a formal information request regarding ibogaine study designs and safety profiles.